Year: 2025

Franklin’s proven financial leadership and strategic expertise will support GF’s continued growth and profitability MALTA, N.Y., Dec. 10, 2025 (GLOBE NEWSWIRE) — GlobalFoundries (GF) today announced that its Board of Directors has appointed Sam Franklin as Chief Financial Officer, effective immediately. Mr. Franklin previously served as Senior Vice President of Business Finance & Operations and Investor Relations and recently Interim CFO. “We are delighted to have Sam formally appointed as CFO,” said Tim Breen, CEO of GF. “His proven leadership and financial expertise will accelerate GF’s momentum and capitalize on the significant opportunities ahead. As we continue to drive profitability and deliver differentiated technologies for the scaling of AI from the data center to the physical world, Sam’s ability to deliver results...

DALLAS, Dec. 10, 2025 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (the “Company”) is deeply saddened to announce the passing of Thomas O. Hicks, Chairman of its Board of Directors (the “Board”), on Saturday, December 6, 2025, at the age of 79. Mr. Hicks was a legendary figure in American business, a pioneer in private equity, and a dedicated leader who brought extraordinary vision, discipline, and experience to Beneficient.A Private Equity Pioneer: Mr. Hicks co-founded Hicks & Haas in 1984 and Hicks, Muse, Tate & Furst in 1989, helping to reshape the private equity landscape with his “buy and build” strategy. A Legacy of Leadership: He served on the Beneficient Board since 2017 and was appointed Chairman in July 2025, providing his decades of seasoned leadership to help guide the Company’s strategic direction. A...

NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Kaya Pai Panandiker, the new Chief Commercial Officer of LB Pharmaceuticals, an equity award outside of, but subject to the terms and conditions of, the LB Pharmaceuticals Inc 2025 Equity Incentive Plan. The equity award was granted on December 10, 2025, pursuant to the “inducement grant” exception provided under Nasdaq Listing Rule 5635(c)(4) as an inducement material to Ms. Pai Panandiker entering into employment with LB Pharmaceuticals. Ms. Pai Panandiker received an option to purchase 195,000 shares of LB Pharmaceuticals’ common stock. The option carries a ten-year term and an exercise price per share equal to $21.36, which was the closing price of LB Pharmaceuticals’...

London, United Kingdom, Dec. 10, 2025 (GLOBE NEWSWIRE) — Daedalus Special Acquisition Corp. (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by Co-Chief Executive Officers Husnu Akin Babayigit and Orkun Kilic, today announced the closing of its upsized pricing of its initial public offering of 25,000,000 units, which includes 2,500,000 units issued pursuant to the partial exercise by the underwriters of their over-allotment option, at an offering price of $10.00 per unit, resulting in gross proceeds of $250,000,000. The units began trading on the Global Market tier of the Nasdaq Stock Market (“Nasdaq”) under the ticker symbol “DSACU” on December 9, 2025. Each unit consists of one Class A ordinary share and one-fourth of one redeemable warrant. Each whole...

Hong Kong, Dec. 10, 2025 (GLOBE NEWSWIRE) — Abits Group Inc. (NASDAQ: ABTS), a new generation digital center with inhouse bitcoin mining operations, today announced its unaudited results for the third quarter ended September 30, 2025 which reflect continued solid progress at both its sites in Tennessee. Highlights of the Quarter  ● Total revenue reached $1.61 million in Duff, Tennessee, representing a 27.5% increase compared to the same period last year. Profit of this self-owned mining operation was $0.76 million, up from $ 0.39 million in Q3 2024.  ● There was a modest profit contribution of $0.43 million from the Mendenhall hosting facility in Memphis  ● Operating profit from operations, before accounting for depreciation and group overheads totalled $1.19 million, an increase of 207.1% over the comparative period last...

BETHESDA, Md., Dec. 10, 2025 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, will report fourth quarter 2025 financial results on Wednesday, February 18, 2026, after the market close. The Company will hold a conference call to discuss its fourth quarter 2025 results and business outlook on Thursday, February 19, 2026, at 10:00 a.m. ET. Conference call access information is as follows:Conference Call:     USA/Canada Toll Free Number  888-715-9871International Toll Number 646-307-1963Conference ID 71987   A simultaneous webcast of the call will be available on the Company’s website at www.hosthotels.com. A replay of the call will be available Thursday, February 19, 2026, until Wednesday, May 6, 2026, via webcast on the...

All amounts in Canadian dollars unless otherwise stated NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION INTHE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. The base shelf prospectus is accessible, and the shelf prospectus supplement for the public offering will be accessible within two business days, through SEDAR+ VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) — Premium Brands Holdings Corporation (“Premium Brands” or the “Company”) (TSX: PBH) is pleased to announce that it has entered into a definitive agreement to indirectly acquire all of the issued and outstanding shares of Stampede Culinary Partners, Inc. (“Stampede”), a leading culinary solutions and protein platform with a nationwide presence in the United States (the “Acquisition”). The...